Prelude Therapeutics Statistics
Total Valuation
PRLD has a market cap or net worth of $66.91 million. The enterprise value is -$23.00 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PRLD has 56.46 million shares outstanding. The number of shares has increased by 12.64% in one year.
| Current Share Class | 43.61M |
| Shares Outstanding | 56.46M |
| Shares Change (YoY) | +12.64% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 7.87% |
| Owned by Institutions (%) | 17.54% |
| Float | 18.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.16 |
| Forward PS | n/a |
| PB Ratio | 0.56 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.18, with a Debt / Equity ratio of 0.17.
| Current Ratio | 5.18 |
| Quick Ratio | 5.01 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -81.44% and return on invested capital (ROIC) is -50.07%.
| Return on Equity (ROE) | -81.44% |
| Return on Assets (ROA) | -45.05% |
| Return on Invested Capital (ROIC) | -50.07% |
| Return on Capital Employed (ROCE) | -115.23% |
| Revenue Per Employee | $53,435 |
| Profits Per Employee | -$975,779 |
| Employee Count | 131 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.27% in the last 52 weeks. The beta is 1.24, so PRLD's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -68.27% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 1.47 |
| Relative Strength Index (RSI) | 69.43 |
| Average Volume (20 Days) | 162,783 |
Short Selling Information
The latest short interest is 877,740, so 1.55% of the outstanding shares have been sold short.
| Short Interest | 877,740 |
| Short Previous Month | 978,610 |
| Short % of Shares Out | 1.55% |
| Short % of Float | 4.84% |
| Short Ratio (days to cover) | 7.58 |
Income Statement
In the last 12 months, PRLD had revenue of $7.00 million and -$127.83 million in losses. Loss per share was -$1.68.
| Revenue | 7.00M |
| Gross Profit | 7.00M |
| Operating Income | -139.98M |
| Pretax Income | -129.85M |
| Net Income | -127.83M |
| EBITDA | -138.20M |
| EBIT | -139.98M |
| Loss Per Share | -$1.68 |
Full Income StatementBalance Sheet
The company has $99.07 million in cash and $17.92 million in debt, giving a net cash position of $81.15 million or $1.44 per share.
| Cash & Cash Equivalents | 99.07M |
| Total Debt | 17.92M |
| Net Cash | 81.15M |
| Net Cash Per Share | $1.44 |
| Equity (Book Value) | 103.18M |
| Book Value Per Share | 1.83 |
| Working Capital | 82.62M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$105.33 million and capital expenditures -$522,000, giving a free cash flow of -$105.85 million.
| Operating Cash Flow | -105.33M |
| Capital Expenditures | -522,000 |
| Free Cash Flow | -105.85M |
| FCF Per Share | -$1.87 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,999.67% |
| Pretax Margin | -1,826.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRLD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.64% |
| Shareholder Yield | -12.64% |
| Earnings Yield | -219.81% |
| FCF Yield | -182.02% |
Analyst Forecast
The average price target for PRLD is $4.50, which is 279.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 279.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 72.06% |
| EPS Growth Forecast (5Y) | -11.96% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRLD has an Altman Z-Score of -6.23 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.23 |
| Piotroski F-Score | 1 |